XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities:    
Consolidated net earnings $ 545.9 $ 538.0
Adjustments to reconcile consolidated net earnings to net cash provided by operating activities:    
Depreciation, depletion and amortization 320.0 292.2
Stock-based compensation expense 33.0 22.4
Gain on divestitures and sales of assets (26.6) (71.2)
Deferred income taxes 25.7 24.8
Other items, net (8.3) 0.8
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Accounts receivable, net (218.0) (104.5)
Inventories, net 65.1 (22.6)
Accounts payable 66.9 (0.8)
Other assets and liabilities, net (23.4) 4.9
Net Cash Provided by Operating Activities 780.3 684.0
Cash Flows from Investing Activities:    
Additions to property, plant and equipment (321.3) (250.8)
Acquisitions, net of cash acquired (792.9) (64.0)
Proceeds from divestitures and sales of assets 41.4 141.2
Investments in life insurance contracts, net 13.9 (12.7)
Other investing activities, net   (5.4)
Net Cash Used for Investing Activities (1,058.9) (191.7)
Cash Flows from Financing Activities:    
Borrowings of debt 2,896.6 628.1
Repayments of debt (400.0) (777.0)
Payments on financing leases (7.6) (2.3)
Debt issuance costs (6.1) (2.0)
Distributions to owners of noncontrolling interest (0.5)  
Repurchases of common stock   (50.0)
Dividends paid (109.7) (104.8)
Proceeds from exercise of stock options 1.1 1.4
Shares withheld for employees' income tax obligations (16.5) (13.0)
Net Cash Provided by (Used for) Financing Activities 2,357.3 (319.6)
Net Increase in Cash, Cash Equivalents and Restricted Cash 2,078.7 172.7
Cash, Cash Equivalents and Restricted Cash, beginning of period 304.4 21.0
Cash, Cash Equivalents and Restricted Cash, end of period $ 2,383.1 $ 193.7